ADAM17 and hepatocellular carcinoma: In parallel, miRNA-dependent down-regulation of ADAM9 [38,39,40], ADAM10 [41,42,43,44,45,46] and ADAM17 [47,48,49,50] was associated with reduced tumor progression, inhibition of cell proliferation and invasion and chemotherapy sensitization of HCC cells.